Methods for simplifying microbial nucleic acids by chemical...

Details Methods for simplifying microbial nucleic acids by chemical... Methods for simplifying microbial nucleic acids by chemical...

2005-12-05

2010-11-16

Lundgren, Jeffrey S (Department: 1639)

Combinatorial chemistry technology: method, library, apparatus

Method of screening a library

C506S008000, C506S009000, C536S025300, C435S091200, C435S005000, C435S006120

Reexamination Certificate

active

07833942

ABSTRACT:
A method for simplification of a microbial genome or microbial nucleic acid comprising treating microbial genome or nucleic acid with an agent that modifies cytosine to form derivative microbial nucleic acid and amplifying the derivative microbial nucleic acid to produce a simplified form of the microbial genome or nucleic acid.

REFERENCES:
patent: 5629156 (1997-05-01), Shah et al.
patent: 5750338 (1998-05-01), Collins et al.
patent: 5786146 (1998-07-01), Herman et al.
patent: 5824517 (1998-10-01), Cleuziat et al.
patent: 5952174 (1999-09-01), Nikiforov et al.
patent: 6156501 (2000-12-01), McGall et al.
patent: 6251637 (2001-06-01), Blusch
patent: 6265171 (2001-07-01), Herman et al.
patent: 6331393 (2001-12-01), Laird et al.
patent: 6692918 (2004-02-01), Kurn
patent: 6960436 (2005-11-01), Cottrell
patent: 7008770 (2006-03-01), Berlin
patent: 7288373 (2007-10-01), Millar et al.
patent: 7413855 (2008-08-01), Bergmann et al.
patent: 7504207 (2009-03-01), Bergquist et al.
patent: 2002/0086324 (2002-07-01), Laird et al.
patent: 2002/0142397 (2002-10-01), Collas et al.
patent: 2003/0073081 (2003-04-01), Mukai et al.
patent: 2003/0082600 (2003-05-01), Olek et al.
patent: 2003/0119025 (2003-06-01), Olek et al.
patent: 2003/0143577 (2003-07-01), Hogrefe et al.
patent: 2004/0067559 (2004-04-01), McCarthy et al.
patent: 2004/0086944 (2004-05-01), Grigg et al.
patent: 2004/0203004 (2004-10-01), Bernard et al.
patent: 2004/0219539 (2004-11-01), Millar et al.
patent: 2005/0019762 (2005-01-01), Olek
patent: 2005/0059003 (2005-03-01), Enoki et al.
patent: 2005/0118578 (2005-06-01), Mineno et al.
patent: 2005/0202490 (2005-09-01), Makarov et al.
patent: 2006/0014144 (2006-01-01), Christensen et al.
patent: 2006/0051771 (2006-03-01), Murphy et al.
patent: 2006/0166203 (2006-07-01), Took
patent: 2006/0286576 (2006-12-01), Lofton-Day
patent: 2007/0020633 (2007-01-01), Millar
patent: 2007/0020639 (2007-01-01), Shapero
patent: 2007/0020653 (2007-01-01), Holliger
patent: 2007/0026070 (2007-02-01), Vonwiller
patent: 2007/0042365 (2007-02-01), Millar et al.
patent: 2007/0178457 (2007-08-01), Millar
patent: 2007/0178459 (2007-08-01), Millar
patent: 2007/0190530 (2007-08-01), Birkner et al.
patent: 2007/0264653 (2007-11-01), Berlin et al.
patent: 2008/0050738 (2008-02-01), Millar
patent: 2009/0029346 (2009-01-01), Millar et al.
patent: 2009/0042732 (2009-02-01), Millar
patent: 2009/0130657 (2009-05-01), Millar
patent: 2009/0263909 (2009-10-01), Millar
patent: 2010/0041013 (2010-02-01), Millar et al.
patent: 2010/0092972 (2010-04-01), Millar et al.
patent: 1 130 113 (2001-09-01), None
patent: 1 319 718 (2003-06-01), None
patent: 1 443 052 (2004-08-01), None
patent: 1 801 213 (2007-06-01), None
patent: WO 98/020157 (1988-05-01), None
patent: WO 95/01456 (1995-01-01), None
patent: WO 95/22623 (1995-08-01), None
patent: WO 97/41254 (1997-11-01), None
patent: WO 97/45559 (1997-12-01), None
patent: WO 98/20157 (1998-05-01), None
patent: WO 98/29108 (1998-07-01), None
patent: WO 99/09211 (1999-02-01), None
patent: WO 99/14226 (1999-03-01), None
patent: WO 99/49081 (1999-09-01), None
patent: WO 00/44934 (2000-08-01), None
patent: WO 00/50869 (2000-08-01), None
patent: WO 01/09374 (2001-02-01), None
patent: WO 01/38565 (2001-05-01), None
patent: WO 01/42493 (2001-06-01), None
patent: WO 01/76451 (2001-10-01), None
patent: WO 02/36821 (2002-05-01), None
patent: WO 02/38801 (2002-05-01), None
patent: WO 02/46452 (2002-06-01), None
patent: WO 02/072880 (2002-09-01), None
patent: WO 02/097065 (2002-12-01), None
patent: WO 03/008623 (2003-01-01), None
patent: WO 03/048732 (2003-06-01), None
patent: WO 03/051901 (2003-06-01), None
patent: WO 03/052132 (2003-06-01), None
patent: WO 03/052133 (2003-06-01), None
patent: WO 03/052134 (2003-06-01), None
patent: WO 2004/015139 (2004-02-01), None
patent: WO 2004 015139 (2004-02-01), None
patent: WO 2004/015139 (2004-02-01), None
patent: WO 2004 015139 (2004-02-01), None
patent: WO 2004/065625 (2004-08-01), None
patent: WO 2004/090166 (2004-10-01), None
patent: WO 2004/096825 (2004-11-01), None
patent: WO 2004/111266 (2004-12-01), None
patent: WO 2005/021778 (2005-03-01), None
patent: WO 2005/021778 (2005-03-01), None
patent: WO 2005/056790 (2005-06-01), None
patent: WO 2006/058393 (2006-06-01), None
patent: WO 2006/066353 (2006-06-01), None
patent: WO 2006/113770 (2006-10-01), None
patent: WO 2007/106802 (2007-09-01), None
patent: WO 2008/109945 (2008-09-01), None
patent: WO 2008/135512 (2008-11-01), None
patent: WO 2009/067743 (2009-06-01), None
patent: WO 2009/070843 (2009-06-01), None
patent: WO 2009/079703 (2009-07-01), None
Zeschnigk (Nucleic Acids Research 2004 vol. 32 p. 1).
Zeschnigk (Sep. 7, 2004) Nucleic Acids Research vol. 32 pp. 1 to 5.
The Supplementary European Search Report issued on corresponding European Patent Application No. EP 05 81 3335, dated Mar. 12, 2009.
Venter et al., “The Sequence of the Human Genome,”Science,vol. 291 (5523): pp. 1304-1351, (2001).
Badal Sushma et al.: “The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation” Virology, vol. 324, No. 2, Jul. 1, 2004, pp. 483-492.
Badal V. et al.: “CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: Genomic hypomethylation correlates with carcinogenic progression” Journal of Virology, the American Society for Microbiology, US, vol. 77, No. 11, Jun. 1, 2003, pp. 6227-6234.
Baleriola C et al.: “Comparison of a novel HPV test with the Hybrid Capture II (hcll) and a reference PCR method shows high specificity and positive predictive value for 13 high-risk human papillomavirus infections” Journal of Clinical Virology, Elsevier, Amsterdam, NL, vol. 42, No. 1, May 1, 2008, pp. 22-26.
NCBI Database Accession No. M24485, Dec. 5, 1994.
European Search Report issued in corresponding European Application No. 06774977, dated Jul. 28, 2009.
Extended European Search Report issued in corresponding European Application No. 05779000.8, dated Dec. 4, 2008.
Extended European Search Report issued in corresponding European Application No. 05821631.8, dated Dec. 7, 2008.
Feng et al.: “Detection of hypermethylated genes in women with and without cervical neoplasia.” Journal of the National Cancer Institute Feb. 16, 2005, vol. 97, No. 4, pp. 273-282.
Gu W. et al, Depletion ofSaccharomyces cerevisiaetRNAHis Guanylyltransferase Thglp leads to uncharged tRNAH is with additional m5C, Mol Cell Biol. Sep. 2005; vol. 25, No. 18, pp. 8191-8201.
International Search Report issued on corresponding PCT Application No. PCT/AU2008/000367, dated May 14, 2008.
International Search Report issued on corresponding PCT Application No. PCT/AU2006/000755, dated Aug. 30, 2006.
Kalantari, Mina et al. “Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia,”Journal of Virology,.vol. 78, No. 23, Dec. 2004, pp. 12762-12772.
Kim T.Y et al: “DNA hypermethylation in gastric cancer” Alimentary Pharmacology & Therapeutics, vol. 20, No. Suppl. 1, Jul. 2004, pp. 131-142.
Kozak et al.: “Influence of secondary structure on binding and migration of 40S ribosomal subunits,” Cell, vol. 19, 1980, pp. 79-90.
Malyukova A.V et al: “Methylation of the Putative Tumor Suppressor Gene RASSF1A in Primary Cervical Tumors” Molecular Biology, Kluwer Academic Publishers-Plenum Publishers, NE, vol. 38, No. 6, Nov. 1, 2004, pp. 857-864.
Narayan, Gopeshwar et al: “Frequent Promoter Methylation of CDH1, DAPK, RARB, and HIC1 Genes in Carcinoma of Cervix Uteri: Its Relationship to Clinical Outcome” Molecular Cancer, Biomed Central, London, GB, vol. 2, No. 1, May 13, 2003, p. 24.
Nousbaum, J. et al., “Prospective Characteristics of Full-Length Hepatitis C Virus NS5A Quasispecies during Induction and Combination Antiviral Therapy,” Journal of Virology, 74, No. 19, pp. 9028-9038 (2000).
Office Action in U.S. Appl. No. 10/543,017 dated Dec. 8, 2008.
Office Action in U.S. Appl. No.

Affiliated with

Also associated with

Rating

Methods for simplifying microbial nucleic acids by chemical... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for simplifying microbial nucleic acids by chemical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for simplifying microbial nucleic acids by chemical... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4177862